21 Sep TomoTherapy files to sell 8.5 million additional shares of stock
Madison, Wis. – TomoTherapy, a Madison medical device manufacturer, has announced the filing of a registration statement with the Securities and Exchange Commission for a proposed secondary offering of 8.5 million shares of its common stock by selling shareholders.
TomoTherapy, which netted about $180 million during an initial public offering of stock in May, will not receive any proceeds from the sale of the shares, but will pay the expenses of the offering, excluding underwriting discounts.
The selling shareholders will grant underwriters the option to acquire an additional 1,275,000 shares to cover any over-allotments.
TomoTherapy manufactures and sells the Hi·Art radiation therapy system for the treatment of cancers.
• Tom Still: High-end exports can distinguish Wisconsin in China’s emerging markets – for now
• TomoTherapy sells first radiation therapy system in China
• TomoTherapy founder says investors should take long view of company performance
• Jim Leonhart: Happy days are here for Wisconsin biotechnology